Intel Says 14A Chip Defect Reduction Is Its Best Progress Since 22nm
5 Articles
5 Articles
Intel Says 14A Chip Defect Reduction Is Its Best Progress Since 22nm
Intel's 14A manufacturing process is reducing chip defects faster than previous nodes, boosting interest from potential foundry customers and marking a significant advancement in chip technology.
Intel Says 14A Chip Defect Reduction Is Its Best Progress Since the 22nm Process, CFO Tells Investors
Intel's 14A manufacturing process is reducing chip defects faster than previous nodes, boosting interest from potential foundry customers and marking a significant advancement in chip technology.
Intel Stock Falls 2.9% as 14A Defect Gains Confront $2.1 Billion Foundry Loss
SANTA CLARA, California, August 30, 2026, 02:08 (EDT) Intel closed Friday at $89.47, down 2.85%, on 86.17 million shares. Intel 14A defect density is falling faster than its internal target curve. Foundry lost $2.09 billion in Q2 despite 31% revenue growth. Intel Corporation (NASDAQ: INTC) shares fell 2.85% Friday as investors weighed promising Intel 14A…
After the problems with 10nm, the canceled 20A, and the difficult ramp-up of new manufacturing processes, Intel is likely to be cautious about making comparisons to its own glory days. All the more remarkable, then, is a statement made by CFO David Zinsner at the Deutsche Bank Technology Conference on August 26, 2026. The defect density of the upcoming 14A process is developing better than Intel's internal target curve, and according to Zinsner,…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
